These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 6701738)

  • 1. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
    Pigott J; Nichols R; Maddox WA; Balch CM
    Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary node metastases in relation to size and location of breast cancers: analysis of 147 patients.
    Kambouris AA
    Am Surg; 1996 Jul; 62(7):519-24. PubMed ID: 8651544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary lymph node dissection: does it have a role in primary breast cancer?
    Pack MS; Thomas RS
    Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast.
    Margolis DS; McMillen MA; Hashmi H; Wasson DW; MacArthur JD
    Surg Gynecol Obstet; 1992 Feb; 174(2):109-13. PubMed ID: 1734568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of the sentinel node in patients with breast carcinoma].
    Nieweg OE; Kapteijn BA; Peterse JL; Rutgers EJ; van Dongen JA; Kroon BB
    Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2235-9. PubMed ID: 8984369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
    Dale PS; Williams JT
    Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node status of T1 primary breast cancer in a diverse population.
    Madan AK; Macareo L; Winfrey K; Beech DJ
    Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.
    Fisher B; Wolmark N; Bauer M; Redmond C; Gebhardt M
    Surg Gynecol Obstet; 1981 Jun; 152(6):765-72. PubMed ID: 7244951
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
    Chevinsky AH; Ferrara J; James AG; Minton JP; Young D; Farrar WB
    Surgery; 1990 Oct; 108(4):612-7; discussion 617-8. PubMed ID: 2218870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of carcinoma of the breast by modified radical mastectomy.
    Papatestas AE; Lesnick GJ
    Surg Gynecol Obstet; 1975 Jan; 140(1):22-6. PubMed ID: 1209469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
    Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.